Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 40.68% vs 36.25% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 61.73% vs 15.82% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 61.05% vs 20.10% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 27.27% vs -18.52% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Titan Biotech With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 29.22% vs 21.18% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 40.68% vs 36.25% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 15.56% vs 61.37% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 61.73% vs 15.82% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 20.18% vs 28.63% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 61.05% vs 20.10% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 40.00% vs -16.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 27.27% vs -18.52% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025